MedPath

Furosemide for prevention 72 hours postpartum hypertension in women with preeclampsia with severe features: A randomized controlled trial

Phase 2
Completed
Conditions
Persistent postpartum hypertension in preeclampsia with severe feature
Preeclampsia, Postpartum period, Hypertension
Registration Number
TCTR20220419002
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
80
Inclusion Criteria

Women who's 15 years old or more with preeclampsia with severe features who was undergone termination of pregnancy at 24 weeks' gestation or more

Exclusion Criteria

1.pre-existing hypertension or taking antihypertensive medication
2.hypokalemia
3.history used of diuretic drug
4.unstable vital signs
5.allergy to furosemide or sulfonylurea
6.severe postpartum complication

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood pressure at 72 hours postpartum 72 hours postpartum Blood pressure measurement in mmHg,Persistent hypertension at 72 hours postpartum 72 hours postpartum systolic blood pressure 140 mmHg or more OR diastolic blood pressure 90 mmHg or more
Secondary Outcome Measures
NameTimeMethod
the use of antihypertensive medication at hospital discharge patient's antihypertensive drug at hospital discharge,Milk ejection performance 3 days postpartum milk ejection score (0-4),Hospital stay after termination at hospital discharge number of days,Potassium level 6 hours after 2nd tab administration blood chemistry lab,creatinine level 6 hours after 2nd tab administration blood chemistry lab
© Copyright 2025. All Rights Reserved by MedPath